Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · Real-Time Price · USD
0.292
-0.005 (-1.75%)
Nov 4, 2024, 4:00 PM EST - Market closed

Cara Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-111.08-118.51-85.47-88.448.41-106.37
Upgrade
Depreciation & Amortization
0.260.261.671.551.020.8
Upgrade
Loss (Gain) From Sale of Assets
----0.07--
Upgrade
Loss (Gain) From Sale of Investments
-0.89-0.40.260.82-0.12-1.38
Upgrade
Stock-Based Compensation
12.0213.7317.7320.7914.8412.57
Upgrade
Other Operating Activities
7.832.68---22.26-15.75
Upgrade
Change in Accounts Receivable
9.770.5-3.26---0.05
Upgrade
Change in Inventory
0.29-0.440.2-2.58--
Upgrade
Change in Accounts Payable
-10.763.285.68-1.02-2.786.04
Upgrade
Change in Income Taxes
---0.81-0.69-0.15
Upgrade
Change in Other Net Operating Assets
12.676.84-15.548.06-3.89-4.94
Upgrade
Operating Cash Flow
-79.91-92.08-78.73-60.09-5.49-109.23
Upgrade
Capital Expenditures
-3.42-2.38-0.04-0.04-0.35-0.02
Upgrade
Sale of Property, Plant & Equipment
---0.07--
Upgrade
Investment in Securities
37.6145.84128.75-4.78-19.93-30.5
Upgrade
Investing Cash Flow
34.1943.46128.71-4.75-20.28-30.52
Upgrade
Issuance of Common Stock
1.121.680.3146.6139.14142.6
Upgrade
Other Financing Activities
35.1836.47----
Upgrade
Financing Cash Flow
36.338.150.3146.6139.14142.6
Upgrade
Net Cash Flow
-9.42-10.4750.29-18.2313.382.86
Upgrade
Free Cash Flow
-83.33-94.45-78.77-60.13-5.84-109.24
Upgrade
Free Cash Flow Margin
-757.78%-450.46%-188.15%-261.10%-4.32%-549.35%
Upgrade
Free Cash Flow Per Share
-1.53-1.74-1.47-1.19-0.12-2.56
Upgrade
Levered Free Cash Flow
-47.5-52.53-46.93-26.51-9.67-58.86
Upgrade
Unlevered Free Cash Flow
-44.69-52.16-46.93-26.51-9.67-58.86
Upgrade
Change in Net Working Capital
-12.06-12.1611.58-6.8728.542.41
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.